Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Borosil Limited is an Indian manufacturer of consumer glassware and scientific labware, operating through two primary divisions: borosilicate glassware for kitchenware (ovenware, cookware, storage) and laboratory glassware for pharmaceutical/research applications. The company competes in India's premium kitchenware segment with brand recognition built over decades, while its scientific division serves domestic pharmaceutical and research institutions with specialized borosilicate products requiring high thermal resistance.
Borosil generates revenue through branded consumer products sold via retail distribution (modern trade, e-commerce, traditional retail) and B2B sales to pharmaceutical/research customers. The 63.3% gross margin reflects premium positioning in consumer glassware versus unbranded alternatives, proprietary borosilicate glass formulations requiring specialized manufacturing, and vertical integration in glass production. Pricing power derives from brand equity in safety/quality (borosilicate's thermal shock resistance), limited domestic competition in premium glassware, and switching costs in laboratory applications where product specifications are critical. The business benefits from India's rising middle class, increasing health consciousness driving demand for chemical-free storage, and pharmaceutical sector growth requiring laboratory consumables.
Domestic consumer demand trends in India's premium kitchenware segment, influenced by discretionary spending patterns and urban household formation rates
Raw material cost inflation particularly soda ash, silica, and energy prices affecting gross margins in glass manufacturing
Market share gains or losses versus unorganized sector and emerging e-commerce brands in consumer glassware
Pharmaceutical sector capex cycles driving laboratory glassware demand from Indian drug manufacturers
E-commerce channel penetration and direct-to-consumer sales growth versus traditional retail distribution
Shift toward alternative materials including stainless steel, silicone, and plastic containers in kitchenware, particularly as younger consumers prioritize portability and durability over traditional glass benefits
Unorganized sector competition in India's consumer glassware market with low-cost manufacturers lacking brand investment but offering significant price discounts, particularly in tier-2/tier-3 cities
Energy cost volatility given glass manufacturing's high energy intensity (furnaces operate at 1400-1600°C continuously), with limited ability to pass through sudden spikes in natural gas or electricity prices
E-commerce platform private labels (Amazon Basics, Flipkart SmartBuy) entering kitchenware with aggressive pricing and leveraging platform distribution advantages
International brands (Pyrex, Luminarc) potentially increasing India market focus through local manufacturing or imports as tariff structures evolve
Margin pressure from organized retail (Big Bazaar, Reliance Retail) demanding higher trade discounts as modern trade penetration increases
Negative free cash flow of -$1.2B despite positive net income indicates significant working capital build or capex intensity, raising questions about cash conversion sustainability and potential equity dilution needs
High capex of $1.0B relative to $11.1B revenue (9% capex intensity) suggests ongoing capacity expansion that may not generate returns if demand growth disappoints or competition intensifies
Operating cash flow turning negative at -$0.2B despite 53.1% operating margins points to working capital management issues or receivables collection challenges that require monitoring
moderate-to-high - Consumer glassware is discretionary spending tied to urban household income growth and consumer confidence in India. During economic slowdowns, households defer premium kitchenware purchases and trade down to unbranded alternatives. The scientific division provides partial counter-cyclicality as pharmaceutical manufacturing is less economically sensitive, but research institution budgets can face pressure during fiscal constraints. The 16.8% revenue growth reflects India's strong consumption trends, but the -22.6% stock decline suggests investor concern about demand sustainability.
Moderate sensitivity through two channels: (1) Consumer financing - while not a major purchase driver for glassware, broader interest rate increases in India reduce discretionary spending capacity for middle-income households through higher EMI burdens on mortgages/vehicles; (2) Valuation multiple compression - as a consumer discretionary stock trading at 2.6x sales and 16.1x EV/EBITDA, rising rates make growth valuations less attractive. The low 0.09 debt/equity ratio minimizes direct financing cost impact on the company itself.
Minimal direct credit exposure. The business operates on cash-and-carry or short payment terms in retail distribution and B2B laboratory sales. The 2.12 current ratio and low leverage indicate strong liquidity. However, indirect credit exposure exists through distributor/retailer financial health and consumer credit availability affecting big-ticket discretionary purchases in India's retail ecosystem.
growth - The 16.8% revenue growth, premium valuation multiples (2.6x sales, 16.1x EV/EBITDA), and India consumption theme attract growth investors betting on rising middle-class spending and brand premiumization. However, the -25.2% one-year return and negative free cash flow have likely caused growth investor rotation, with current holders potentially value-oriented investors seeing the 3.6x price/book as reasonable given 9.3% ROE and India's long-term consumption trajectory. The 6.7% net margin and modest ROE suggest this is not a compounder attracting quality-focused growth investors.
high - As a mid-cap Indian consumer discretionary stock with significant retail investor participation, Borosil exhibits elevated volatility. The -22.6% three-month decline demonstrates sensitivity to sentiment shifts around India consumption, raw material cost concerns, or broader emerging market risk-off moves. Limited institutional ownership and lower liquidity versus large-cap Indian consumer names amplify price swings on modest volume changes.
